Creating impact and developing innovation in great company
Roslin Innovation Centre opened for business at the end of August 2017 and reached an occupancy of 95% in 2023, accommodated across our office and lab space.
Tenants are international in their outlook and a dynamic mix of established, local/multinational, start-up/spin out companies; social enterprise and internal University business units - each with innovation at their core.
In the early years, we were joined by tenant companies relocating from local science and research parks and companies from within the Easter Bush Campus, and many of these remain 'in residence' as they have expanded. We have continued to welcome new tenants, from within the UK and from around the globe including New Zealand, USA and Europe.
AbacusBio Ltd applies world class science and technology to improve and enhance the performance, resilience, competitiveness, responsiveness, and profitability of their clients’ enterprises.
AbacusBio is a highly respected science and technology consulting firm operating from offices in New Zealand and the United Kingdom. The firm delivers world class solutions for clients across the agribusiness world.
AbacusBio moved in to our open-plan office space in August 2017 and from this UK base provide independent services and products to industry organisations, businesses, universities, and investment groups.
Thomas Farrugia of Beta Bugs was announced as a Royal Society of Edinburgh (RSE) Unlocking Ambition Enterprise Fellow in June 2018 following successful completion of the Unlocking Ambition Challenge.
Beta Bugs accelerate insect evolution, creating new breeds of commercially farmed insects for the alternative protein industry and make them into next-gen crops that will drive a sustainable bio economy.
Roslin Innovation Centre is hosting the entrepreneurial start-up as part of this new programme supported by Scottish Government and RSE.
Carcinotech Ltd, is a MedTech company with expertise in manufacturing 3D printed tumours using patient-derived cancer stem cells, primary cells and established cell lines. Advanced models provide a platform for rapid, ethical, sustainable, and accurate drug discovery, screening, and pre-clinical testing.
Working with global partners, leading pharma companies, surgeons, pathologists, clinicians, and industry-leaders, the goal is to accelerate drug discovery and enable delivery of more effective cancer treatments to market.
Access to Carcinotech’s AI-driven automated manufacturing allows for accelerated production, with models offering high-throughput capabilities and provides an alternative to animal testing and an accurate precision medicine testing platform.
In March 2021, Axol Bioscience Ltd, an established provider of iPSC-derived cells, media, and characterisation services, merged with Censo Bio, a cell biology CRO with focused expertise in iPSC-related technologies. Read more
Censo Bio lease lab and office space at Roslin Innovation Centre and develop models of disease using cells from a diverse range of patients using its capabilities to generate induced Pluripotent Stem Cells (iPSCs).
The company enables the discovery and development of new targeted treatments for disease by utilising the power of stem cells; supporting global pharma and biotech industry in their search for new treatments for neurological diseases such as Alzheimer’s and Parkinson’s.
Greengage Agritech Ltd joined us during our development phase in 'pop up incubator' space in 2015 and expanded this with an extra unit in 2016. The team have since relocated in stages to Roslin Innovation Centre.
Greengage delivers LED agricultural lighting, sensors and control systems for improved farming environments for poultry, pigs and cattle.
The company is a leading global manufacturer of "ALIS" an LED (Light Emitting Diode) lighting and induction power system.
Ingenza Ltd, a spin-out from the University of Edinburgh founded in 2002, is led by a management team with over 25 years’ experience in applied bioscience and the development and commercialisation of biobased products.
Following the closure of the neighbouring Roslin BioCentre, Ingenza relocated to customised lab and office space at Roslin Innovation Centre at the end of July 2018.
The company has integrated teams of scientists, bringing together expertise across synthetic chemistry, informatics, molecular genetics, biochemistry and fermentation scale-up.
Macomics Ltd is an immuno-oncology company with world-leading expertise in macrophage biology, developing precision medicines to modulate macrophages for the treatment of cancer.
A spin-out from the University of Edinburgh, co-founded in 2020 by internationally recognised leaders in macrophage biology, Professor Jeffrey Pollard and Dr Luca Cassetta, the target discovery platform enables the identification and validation of novel macrophage therapeutic targets and is based on its deep understanding of macrophage biology.
We welcome Macomics to Roslin Innovation Centre as they expand their scientific team to support its accelerated R&D to develop a new approach to targeting the immunosuppressive tumour microenvironment, that exploits disease-specific macrophage biology to harness the power of the entire immune system.
N2 Pharmaceuticals Ltd located to Roslin Innovation Centre in December 2018.
The company has developed N2-01, a unique injectable medicine extracted from meat of Blue mussels, that has proven in laboratory settings and during its usage on animals, to reduce the level of endothelial dysfunction.
The medicine proved to be effective in numerous conditions when used on more than 25,000 companion and food producing animals by practicing veterinarians. Results of treatment improved recovery, quality of life or as a supportive treatment for cats and dogs and in dairy cattle, the treatment improved the effectiveness of artificial insemination.
N2 Pharmaceuticals is currently working on the compound's registration with the European Medical Agency. The technology has numerous patents in the UK, EU, USA and Russia.
Prozymi Biolabs develops revolutionary technologies that can transform the taste and quality of gluten-free bread and baked products using naturally occurring enzymes to specifically target and degrade the toxic parts of gluten.
In 2021, the start-up company received seed funding from the University of Edinburgh Data Driven Entrepreneurship programme, while in 2022 won the Wild Card EDGE R19 in the Scottish Edge Competitions and a SMART: SCOTLAND grant from Scottish Enterprise.
We welcome the Prozymi Biolabs team to Roslin Innovation Centre, and perhaps sampling some gluten-free products baked full of flavour in a traditional way!
Roslin Technologies Ltd is an agriculture biotechnology company and focus on the development of novel agritech products as well as offering a range of commercial services, licensing and collaboration opportunities.
Business Gateway Midlothian offers expert help and support to new and existing businesses, including directing to grants and funding opportunities through connections with Scottish Enterprise and associated funding bodies.
Business Growth Advisors can tailor a strategic action plan to mirror your business ambition; covering aspects such as finance, digital marketing, innovation, sales and business development, or other associated business requirements, to assist in growth.
On a regular basis, a Business Growth Consultant will be based in our open plan office space. Guest Surgeries will be hosted at Roslin Innovation Centre and one-to-one appointments can be arranged.
The City Region Deal is a mechanism for driving productivity and accelerating growth by pulling in significant government investment in innovation, skills and infrastructure.
Easter Bush Campus is one of a network of five hubs in the Data-Driven Innovation Programme (DDI). The project will seek to leverage existing world-class research institutes and commercialisation facilities to make Easter Bush a global location of Agritech sector excellence through the deployment of a campus-wide network that will generate and collate local and global data.
For further information, please contact Helen Dundas, Agritech Innovation and Enterprise Lead.
The Midlothian Science Festival launched in 2012 and takes place annually in October at venues throughout the Midlothian region, with the majority of events free to attend.
In 2021 and 2022 the festival was a virtual one with a Schools Programme, developed and coordinated by Easter Bush Science Outreach Centre and made possible by local scientists and STEM organisations.
The overall aim is to provide a programme of fun, interesting and accessible science events and activities across Midlothian to demonstrate that science is everywhere - and for everyone. We hope 2023 will be back to in-person events and will announce date and programme when this is available later in the year.
Midlothian Science Zone is represented by partners from science, technology and innovation parks; research institutes; academic institutions and tenant companies located 'in the zone' with a focus on animal health, human health, aquaculture and related sectors.
This collaborative One Health community offers access to knowledge and expertise, resources and facilities, new technologies, accommodation and services, business support and networks across the Midlothian region.
A member of the Midlothian Science Zone team is generally onsite each week, based in open plan office space at Roslin Innovation Centre. Emma McCallum, was appointed project coordinator in October 2021 and is supported by Lesley Parsons who maintains the digital assets.
Oxitec Ltd is building a healthy, sustainable and equitable future for humans on this planet by forging a new category of safe, sustainable, highly effective biological pest control solutions.
The company is the leading developer of biological solutions to control pests that transmit disease, destroy crops and harm livestock. The Friendly™ platform is being applied to combat the growing threat posed by disease-transmitting mosquitoes and agricultural pests that damage crops and livestock, threatening food security and livelihoods.
Work is conducted in partnership with the Roslin Institute, and focuses specifically on the world’s most devastating invasive cattle tick.
Oxitec will move into open-plan office space at Roslin Innovation Centre in September 2023 and, from 2024, will be based at our new Agri Field Station.
Please contact us if you are interested in joining us at Roslin Innovation Centre, in the heart of the University of Edinburgh's Easter Bush Campus, with laboratory and office space situated close to the science and clinical livestock expertise and providing opportunity for the natural development of business collaborators.
Whilst it's always sad to see tenants move on from Roslin Innovation Centre, we hope the time spent with us was a rewarding one and that our supportive community and flexible office and lab facilities played a part in supporting them at whatever stage they were at.
We wish all tenants the very best success for the future.
"Our aim is to attract up to 30 tenant companies, and ideally for these to be strategically collaborating with the Roslin Institute and others on Campus."John Mackenzie, former CEO of Roslin Innovation Centre (November 2014 - March 2022)